D.L. Guernsey
About
In The Last Decade
D.L. Guernsey
22 papers receiving 674 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 349
- Surgery 159
- Cellular and Molecular Neuroscience 131
- Oncology 82
- Gastroenterology 78
Countries citing papers authored by D.L. Guernsey
This map shows the geographic impact of D.L. Guernsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Guernsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Guernsey more than expected).
Fields of papers citing papers by D.L. Guernsey
This network shows the impact of papers produced by D.L. Guernsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Guernsey. The network helps show where D.L. Guernsey may publish in the future.
Co-authorship network of co-authors of D.L. Guernsey
This figure shows the co-authorship network connecting the top 25 collaborators of D.L. Guernsey. A scholar is included among the top collaborators of D.L. Guernsey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.L. Guernsey. D.L. Guernsey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | 12 | |
| 3 | 15 | |
| 4 | 8 | |
| 5 | 143 | |
| 6 | 79 | |
| 7 | 7 | |
| 8 | 59 | |
| 9 | Lattice corneal dystrophy type I in a Canadian kindred is associated with the ARG124 - CYS mutation in the kerato-epithelin gene | 3 |
| 10 | 7 | |
| 11 | 4 | |
| 12 | 125 | |
| 13 | 6 | |
| 14 | Increased messenger RNA levels of the antagonist thyroid hormone receptor erbA-alpha 2 and decreased levels of erbA-alpha 1 and erbA-beta 1 receptor messenger RNAs in neoplastic rodent cells. | 7 |
| 15 | 4 | |
| 16 | 13 | |
| 17 | 41 | |
| 18 | In vitro modulation of oncogenesis and differentiation by retinoids and tumor promoters. | 3 |
| 19 | 31 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.